» Articles » PMID: 33590857

Exposure to Nicotine and Toxicants Among Dual Users of Tobacco Cigarettes and E-Cigarettes: Population Assessment of Tobacco and Health (PATH) Study, 2013-2014

Abstract

Introduction: Concurrent use of tobacco cigarettes and e-cigarettes ("dual use") is common among tobacco users. Little is known about differences in demographics and toxicant exposure among subsets of dual users.

Aims And Methods: We analyzed data from adult dual users (current every/some day users of tobacco cigarettes and e-cigarettes, n = 792) included in the PATH Study Wave 1 (2013-2014) and provided urine samples. Samples were analyzed for biomarkers of exposure to nicotine and selected toxicants (tobacco-specific nitrosamine NNK [NNAL], lead, cadmium, naphthalene [2-naphthol], pyrene [1-hydroxypyrene], acrylonitrile [CYMA], acrolein [CEMA], and acrylamide [AAMA]). Subsets of dual users were compared on demographic, behavioral, and biomarker measures to exclusive cigarette smokers (n = 2411) and exclusive e-cigarette users (n = 247).

Results: Most dual users were predominant cigarette smokers (70%), followed by daily dual users (13%), non-daily concurrent dual users (10%), and predominant vapers (7%). Dual users who smoked daily showed significantly higher biomarker concentrations compared with those who did not smoke daily. Patterns of e-cigarette use had little effect on toxicant exposure. Dual users with high toxicant exposure were generally older, female, and smoked more cigarettes per day. Dual users who had low levels of biomarkers of exposure were generally younger, male, and smoked non-daily.

Conclusions: In 2013-2014, most dual users smoked cigarettes daily and used e-cigarettes occasionally. Cigarette smoking appears to be the primary driver of toxicant exposure among dual users, with little-to-no effect of e-cigarette use on biomarker levels. Results reinforce the need for dual users to stop smoking tobacco cigarettes to reduce toxicant exposure.

Implications: With considerable dual use of tobacco cigarettes and e-cigarettes in the United States, it is important to understand differences in toxicant exposure among subsets of dual users, and how these differences align with user demographics. Findings suggest most dual users smoke daily and use e-cigarettes intermittently. Low exposure to toxicants was most common among younger users, males, and intermittent smokers; high exposure to toxicants was most common among older users, females, and heavier cigarette smokers. Results underscore the heterogeneity occurring within dual users, and the need to quit smoking cigarettes completely in order to reduce toxicant exposure.

Citing Articles

Single and multiple tobacco product use among people with disabilities: Findings from the National Health Interview Survey, 2019-2022.

Schulz J, Ganz O, Rubenstein D, West J, Klemperer E Addict Behav. 2025; 164:108283.

PMID: 39923385 PMC: 11878199. DOI: 10.1016/j.addbeh.2025.108283.


Biomarkers of Exposure to Nicotine and Selected Toxicants in Individuals Who Use Alternative Tobacco Products Sold in Japan and Canada from 2018 to 2019.

Miller C, Schneller-Najm L, Leigh N, Agar T, Quah A, Cummings K Cancer Epidemiol Biomarkers Prev. 2024; 34(2):298-307.

PMID: 39636163 PMC: 11799835. DOI: 10.1158/1055-9965.EPI-24-0836.


The effects of electronic cigarette use patterns on health-related symptom burden and quality of life: analysis of US prospective longitudinal cohort study data.

Cao Y, Zhang X, Fearon I, Li J, Chen X, Xiong Y Front Public Health. 2024; 12:1433678.

PMID: 39606086 PMC: 11600979. DOI: 10.3389/fpubh.2024.1433678.


Modeling the Impact of Vaping: What We Need to Know and Which Methods to Use.

Shahab L Nicotine Tob Res. 2024; 27(3):561-563.

PMID: 39223905 PMC: 11847779. DOI: 10.1093/ntr/ntae204.


A review of vaping's health effects, treatment, and policy implications: Nursing's call to action.

Buettner-Schmidt K, Fraase K, Barnacle M, Peltier A, Saarinen H, Maack B Nurse Pract. 2024; 49(9):36-47.

PMID: 39186124 PMC: 11343445. DOI: 10.1097/01.NPR.0000000000000221.


References
1.
Xia B, Xia Y, Wong J, Nicodemus K, Xu M, Lee J . Quantitative analysis of five tobacco-specific N-nitrosamines in urine by liquid chromatography-atmospheric pressure ionization tandem mass spectrometry. Biomed Chromatogr. 2013; 28(3):375-84. DOI: 10.1002/bmc.3031. View

2.
DRuiz C, Graff D, Robinson E . Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes. BMC Public Health. 2016; 16:543. PMC: 4940751. DOI: 10.1186/s12889-016-3236-1. View

3.
Byrd G, Chang K, Greene J, deBethizy J . Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3'-hydroxycotinine in smokers. Drug Metab Dispos. 1992; 20(2):192-7. View

4.
Strasser A, Souprountchouk V, Kaufmann A, Blazekovic S, Leone F, Benowitz N . Nicotine Replacement, Topography, and Smoking Phenotypes of E-cigarettes. Tob Regul Sci. 2016; 2(4):352-362. PMC: 5142626. DOI: 10.18001/TRS.2.4.7. View

5.
Borland R, Murray K, Gravely S, Fong G, Thompson M, McNeill A . A new classification system for describing concurrent use of nicotine vaping products alongside cigarettes (so-called 'dual use'): findings from the ITC-4 Country Smoking and Vaping wave 1 Survey. Addiction. 2019; 114 Suppl 1:24-34. PMC: 6669110. DOI: 10.1111/add.14570. View